UMIN ID: UMIN000055414
Registered date:17/09/2024
Fatigue Improvement Intervention Study
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Not applicable |
Date of first enrollment | 2024/09/17 |
Target sample size | 100 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Perform light exercise for 30 minutes per day, 5 weekdays (Monday upon waking to Friday upon waking)-Extending the average time in bed by 1.2 times per day for 5 weekdays (from Monday waking time to Friday waking time) Extending the average time in bed by 1.2 times per day for 5 weekdays (from Monday waking time to Friday waking time)-Perform light exercise for 30 minutes per day, 5 weekdays (Monday upon waking to Friday upon waking) |
Outcome(s)
Primary Outcome | Relationship between the amount of change in waking fatigue before and after the intervention and baseline measurement data |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 59years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. Person who currently suffers from chronic diseases (diabetes, hypertension, hyperlipidemia, gout, renal disease, rheumatic or respiratory disease, etc.) and are taking medication (however, users of drugs to control allergic symptoms such as allergic rhinitis shall be included in the target population). 2. Person who is unable to participate in the study due to liver, renal, cardiac, respiratory, endocrine, metabolic, neurological, consciousness, diabetes, or other diseases. 3. Patient with insomnia, sleep apnea syndrome, or other sleep disorders. 4. Patient with chronic fatigue syndrome 5. Patient taking sleeping pills 6. Person who drinks a lot of alcohol (alcohol equivalent of 60g/day or more: (beer: 3 medium bottles (1.5L), sake: 3 gou (540ml), whiskey: 3 double drinks (180ml), shochu: 1.8 gou (330ml) or more). 7. Patient with skin diseases (atopic dermatitis, acne vulgaris, psoriasis, etc.) on the face. 8. Person who uses topical medical products on the face. 9. Patient with excessive sunburn on the face. 10. Person who is currently participating in other human clinical trials or have participated in other drug or food trials within the past month or are planning to participate in other trials in the future during the period of this study. 11. Person who is not on a day shift, such as night work or rotating shifts. 12. Person who is currently pregnant or wish to become pregnant during the study participation period. 13. Person with a history or current history of drug or alcohol dependence. 14. Person who is planning to travel, go on business, or go on vacation during the measurement period. 15. Person who does not own a smart phone and is unable to complete the questionnaire via an app or web browser. 16. Person who is deemed inappropriate for the study by the principal investigator. |
Related Information
Primary Sponsor | Kao Corporation |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Kao Corporation |
Secondary ID(s) |
Contact
public contact | |
Name | Keita Kinoshita |
Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN 131-8501 |
Telephone | +81-3-5630-7268 |
sugitani.kei@kao.com | |
Affiliation | Kao Corporation Human Health Care Products Research Lab. |
scientific contact | |
Name | Masanobu Hibi |
Address | 2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN |
Telephone | +81-3-5630-7268 |
hibi.masanobu@kao.com | |
Affiliation | Kao Corporation Human Health Care Products Research Lab. |